dc.contributor.author |
Litvin Y. |
|
dc.contributor.author |
Zakirova E. |
|
dc.contributor.author |
Zhuravleva M. |
|
dc.contributor.author |
Rizvanov A. |
|
dc.date.accessioned |
2018-09-19T23:12:04Z |
|
dc.date.available |
2018-09-19T23:12:04Z |
|
dc.date.issued |
2016 |
|
dc.identifier.issn |
2191-1630 |
|
dc.identifier.uri |
https://dspace.kpfu.ru/xmlui/handle/net/146053 |
|
dc.description.abstract |
© 2016, Springer Science+Business Media New York.In this study, we have generated a dual expression cassette plasmid DNA (pDNA) construct containing the species-specific horse (Equus caballus) codon optimized sequence encoding potent pro-angiogenic vascular endothelial growth factor (VEGF164) and basic fibroblast growth factor (FGF2) under eukaryotic promoters (EF-1α and CMV promoters, respectively). We have demonstrated effective and simultaneous recombinant proteins expression in vitro. Resulting pDNA is suitable for potential gene therapy applications in horses. |
|
dc.relation.ispartofseries |
BioNanoScience |
|
dc.subject |
Fibroblast growth factor 2 |
|
dc.subject |
Gene therapy |
|
dc.subject |
Horse |
|
dc.subject |
Plasmid DNA |
|
dc.subject |
Vascular endothelial growth factor 164 |
|
dc.title |
Generation of Plasmid DNA Expressing Species-Specific Horse VEGF164 and FGF2 Factors for Gene Therapy |
|
dc.type |
Article |
|
dc.relation.ispartofseries-issue |
4 |
|
dc.relation.ispartofseries-volume |
6 |
|
dc.collection |
Публикации сотрудников КФУ |
|
dc.relation.startpage |
550 |
|
dc.source.id |
SCOPUS21911630-2016-6-4-SID84999836876 |
|